WebMD to acquire QualityHealth.com

Share this article:

WebMD has announced plans to acquire QualityHealth.com, and its parent, Marketing Technology Solutions, for $50 million.

The acquisition, announced in a statement September 15, will “add performance-based marketing programs to WebMD's extensive product portfolio and expands the breadth of its offerings to the biopharmaceutical and healthcare markets,” said the statement. The acquisition is expected to close in 30 days.

“Adding QualityHealth.com…will enable us to deliver even greater value to our coustomers and capture a larger share of overall consumer marketing budgets,” said Wayne Gattinella, CEO, WebMD, in the statement. 

In June, Wall Street analysts reported that WebMD was bringing in fewer advertising dollars and facing competition from smaller, similar websites. Most recently, WebMD announced a partnership with Euro RSCG Life parent HAVAS for a new virtual convention booth offering healthcare professionals a 3D interactive experience online.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...